Status:
TERMINATED
Therapeutic Exercise in Patients With Hemophilia
Lead Sponsor:
University of Seville
Conditions:
Hemophilia
Eligibility:
MALE
30-45 years
Phase:
NA
Brief Summary
Objectives: To assess the efficacy of performing a therapeutic exercise program, compared with usual care, on pain relief, range of movement and self-perceived quality of life in patients with hemophi...
Eligibility Criteria
Inclusion
- Clinical diagnosis of hemophilia type A or hemophilia type B.
- Knee, elbow or ankle arthropathy caused by hemophilia
- Pharmacological treatment based on using VIII or IX factor concentrates.
Exclusion
- Presence of VIII FIX inhibitors.
- Having received anti-inflammatory treatment using Arcoxia (Etoricoxib)
- Having undergone a surgical intervention at the target joint.
- Patients enrolled in other research which implies doing physical exercise.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04114448
Start Date
April 1 2021
End Date
April 1 2023
Last Update
May 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sevilla
Seville, Spain, 41009